The melanoma cell line WM3211, derived from the primary lesion (VGP) and wild type for BRAF, PTEN, N-RAS, and CDK4 and with a mutation at position 576 in the c-KIT gene, showed the lowest tendency to activate caspase-3. This evidence concerns the gene BRAF and melanoma.